Strength for Health

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01882972
Recruitment Status : Withdrawn (investigator left Loyola)
First Posted : June 21, 2013
Last Update Posted : April 15, 2015
Hygenic Corporation
Information provided by (Responsible Party):
Kate Wolin, Loyola University Chicago

Brief Summary:
Despite a robust literature on the benefits of exercise for cancer survivors, most of the research to date falls in two primary areas - aerobic exercise and breast cancer survivors. The focus on aerobic training alone is a concern as resistance training is critical for building the muscle mass necessary to maintain physical function. However, concerns have been raised about the potential for higher than tolerated adverse event rates during resistance training, particularly that which is unsupervised, despite a history of safe use of resistance training in other chronically diseased patient populations. The aim of this pilot study is to demonstrate the feasibility, safety and quality of life benefit of a home-based resistance-training program among colorectal cancer survivors. The investigators will recruit n=30 men and women with stage I-III colon cancer. Participants will be randomized to a home-based exercise intervention that combines aerobic and resistance exercise. Control arm participants will receive a home-based meditation program.

Condition or disease Intervention/treatment Phase
Colon Cancer Behavioral: Exercise Behavioral: Meditation Not Applicable

Detailed Description:
The investigators will recruit n=30 patients with stage I-III colorectal cancer and randomize them to a 12-week resistance training intervention with Theraband and existing evidence- based materials or attention control using a meditation intervention. Using an electronic survey tool, patients will complete a baseline questionnaire on key outcomes (quality of life, fatigue, side effects) and potential confounders and will consent to a medical record review. These will also be assessed via at 4 weeks post randomization and 12 weeks post randomization. Participants in the intervention group will receive one-time in person instruction in the exercises derived from the existing evidence base of home-based resistance training programs for older adults and cancer survivors. They will be sent home with a book demonstrating the exercises, a log and a set of appropriate resistance bands. Weekly follow-up calls will occur for the duration of the intervention and updates on the call results will be provided to the colon cancer clinic nurse so that care is integrated. Participants in the attention control group will be mailed a meditation CD. Follow-up in the control group will parallel that of the intervention group, with weekly calls.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 0 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Supportive Care
Official Title: Safety and Efficacy of Home-based Resistance Training in Colorectal Cancer Survivors
Study Start Date : June 2013
Actual Primary Completion Date : September 2013
Actual Study Completion Date : September 2013

Resource links provided by the National Library of Medicine

Arm Intervention/treatment
Experimental: Exercise
Exercise 12 week home-based resistance exercise training intervention. Participants will be coached to engage in resistance training 3 days per week and aerobic exercise for 30 minutes at least 5 days per week for 12 weeks.
Behavioral: Exercise
Other Name: Home-based exercise using Therabands

Placebo Comparator: control
Participants in the attention control arm will not be asked to cease activity they already participate in but will be instructed not to begin a new exercise program for 12 weeks. Participants will receive a meditation CD to use daily to account for the time intervention arm participants are engaged in exercise.
Behavioral: Meditation
Other Name: A healing meditation for cancer patients CD

Primary Outcome Measures :
  1. Feasibility of recruitment [ Time Frame: 14 months ]
    Ability to meet the recruitment goal of 30 subjects in a 14 month period, reflecting a participation rate of at least 20% among approached and eligible patients

  2. Retention feasibility [ Time Frame: 14 months ]
    Retention of at least 80% of randomized patients to the follow-up visit. A drop-out rate of less than 20%

Secondary Outcome Measures :
  1. Pain [ Time Frame: 12 weeks ]
    Change in participant reported pain from baseline to 12 weeks

  2. quality of life [ Time Frame: 12 weeks ]
    Change in Quality of life score as measured by the FACT-C and FACT-F from baseline to 12 weeks

  3. Surgical Complications [ Time Frame: 12 weeks ]
    Difference in rate of reported surgical complications between arms at 12 weeks

  4. Self-reported Exercise-related Injury [ Time Frame: 12 weeks ]
    difference in self reported exercise-related injury rate between arms at 12 weeks

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • stage I-III colorectal cancer
  • completed surgical treatment
  • at least 12 weeks post-surgery.
  • at least 4 weeks post adjuvant therapy.
  • age 18 and older.

Exclusion Criteria:

  • patients who had surgery more than 24 months ago.
  • patients with related pre-existing conditions (i.e., Crohn's disease, ulcerative colitis, familial polyposis syndromes).

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01882972

United States, Illinois
Loyola University Chicago
Maywood, Illinois, United States, 60153
Sponsors and Collaborators
Loyola University
Hygenic Corporation
Principal Investigator: Kathleen Wolin, ScD Loyola University Chicago

Responsible Party: Kate Wolin, Associate Professor, Loyola University Chicago Identifier: NCT01882972     History of Changes
Other Study ID Numbers: 205243
First Posted: June 21, 2013    Key Record Dates
Last Update Posted: April 15, 2015
Last Verified: April 2015